Jason Matuszewski, CEO of BioStem Technologies Inc. BSEM, was a guest speaker at Benzinga’s All Access on June 17th, 2022.
BioStem Technologies Inc. is a pre-clinical-stage biotechnology company that has developed a proprietary approach, called Local MicroEnvironment Activation, to harness elements of Perinatal Tissue and the body’s innate biology to repair or reverse damage caused by a variety of degenerative diseases.
Watch the full interview here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in